Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Manish DhyaniJoseph R GrajoDayron RodriguezZhikui ChenAdam FeldmanRosemary TambouretDebra A GervaisRonald S ArellanoPeter F HahnAnthony E SamirPublished in: Abdominal radiology (New York) (2017)
Nephrographic phase ALAD has potential to differentiate benign and malignant oncocytic renal neoplasms on contrast-enhanced CT if histologic evaluation on biopsy is indeterminate.
Keyphrases